Kenneth Hoberman insider trades: Nuvectis Pharma (NVCT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 12, 2022 | NVCT | ↑ Buy | 6,000 | $17.40 | $104K | Direct | May 16, 2022 (4d) |
| Mar 10, 2020 | STML | ↓ Sell | 26,191 | $4.97 | $130K | Direct | Mar 13, 2020 (3d) |
| Feb 25, 2020 | STML | ↓ Sell | 11,547 | $6.42 | $74K | Direct | Feb 28, 2020 (3d) |
| Jan 22, 2020 | STML | ↓ Sell | 22,139 | $7.02 | $155K | Direct | Jan 24, 2020 (2d) |
| Jan 8, 2020 | STML | ↓ Sell | 13,228 | $10.37 | $137K | Direct | Jan 10, 2020 (2d) |
| Dec 27, 2019 | STML | ↓ Sell | 46,312 | $10.84 | $502K | Direct | Jan 3, 2020 (7d) |
| Jun 26, 2019 | STML | ↓ Sell | 47,115 | $15.07 | $710K | Direct | Jun 28, 2019 (2d) |
| May 14, 2019 | STML | ↓ Sell | 25,817 | $14.27 | $368K | Direct | May 17, 2019 (3d) |
| Mar 12, 2019 | STML | ↓ Sell | 26,082 | $11.11 | $290K | Direct | Mar 15, 2019 (3d) |
| Mar 7, 2019 | STML | ↓ Sell | 2,995 | $11.36 | $34K | Direct | Mar 8, 2019 (1d) |
| Feb 25, 2019 | STML | ↓ Sell | 10,557 | $12.05 | $127K | Direct | Feb 27, 2019 (2d) |
| Jan 8, 2019 | STML | ↓ Sell | 13,547 | $10.15 | $138K | Direct | Jan 11, 2019 (3d) |
| Nov 26, 2018 | STML | ↓ Sell | 26,296 | $11.85 | $312K | Direct | Nov 30, 2018 (4d) |
| Mar 13, 2018 | STML | ↓ Sell | 29,987 | $17.14 | $514K | Direct | Mar 14, 2018 (1d) |
| Mar 7, 2018 | STML | ↓ Sell | 3,027 | $16.55 | $50K | Direct | Mar 9, 2018 (2d) |
| Feb 27, 2018 | STML | ↓ Sell | 11,026 | $17.43 | $192K | Direct | Feb 28, 2018 (1d) |
| Feb 15, 2018 | STML | ↓ Sell | 1,851 | $15.67 | $29K | Direct | Feb 16, 2018 (1d) |
| Jan 8, 2018 | STML | ↓ Sell | 14,040 | $13.93 | $196K | Direct | Jan 12, 2018 (4d) |
| Dec 18, 2017 | STML | ↓ Sell | 11,983 | $14.18 | $170K | Direct | Dec 19, 2017 (1d) |
| Mar 7, 2017 | STML | ↓ Sell | 2,342 | $8.16 | $19K | Direct | Mar 9, 2017 (2d) |
| Feb 28, 2017 | STML | ↓ Sell | 8,027 | $6.99 | $56K | Direct | Mar 1, 2017 (1d) |
| Feb 16, 2017 | STML | ↓ Sell | 1,508 | $6.42 | $10K | Direct | Feb 17, 2017 (1d) |
| Jan 10, 2017 | STML | ↓ Sell | 9,110 | $13.82 | $126K | Direct | Jan 13, 2017 (3d) |
| Mar 8, 2016 | STML | ↓ Sell | 2,412 | $5.34 | $13K | Direct | Mar 10, 2016 (2d) |
| Feb 17, 2016 | STML | ↓ Sell | 1,503 | $4.54 | $7K | Direct | Feb 19, 2016 (2d) |
| Mar 19, 2015 | STML | ↓ Sell | 17,307 | $16.43 | $284K | Direct | Mar 20, 2015 (1d) |
| Feb 18, 2015 | STML | ↓ Sell | 1,593 | $14.02 | $22K | Direct | Feb 20, 2015 (2d) |
| Sep 2, 2014 | STML | ↑ Buy | 2,000 | $10.99 | $22K | Direct | Sep 3, 2014 (1d) |
| May 21, 2014 | STML | ↓ Sell | 15,250 | $13.32 | $203K | Direct | May 23, 2014 (2d) |
| Nov 27, 2013 | STML | ↓ Sell | 44,428 | $20.72 | $921K | Direct | Nov 27, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCT insiders
Open-market trades in the last 12 months
About Kenneth Hoberman's insider trades
Kenneth Hoberman is a director at Nuvectis Pharma (NVCT). Since Nov 27, 2013, Kenneth has reported 2 open-market purchases worth $126K and 28 sales worth $5.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (27 filings), option exercises (2 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.